
معرفی
Virginia Gao, M.D., Ph.D., is an Assistant Professor of Neurology and Neuroscience at Weill Cornell Medical College, Cornell University, and a board-certified neurologist specializing in Movement Disorders at NewYork-Presbyterian Hospital. As the Louis and Rachel Rudin Clinical Scholar in Neurology, she directs clinical care at the Parkinson's Disease & Movement Disorders Institute while leading biomarker discovery research and medical education initiatives.
Her educational background includes:
- B.A. in Neuroscience from Columbia University (2008)
- M.D. and Ph.D. from Mount Sinai School of Medicine (2018)
- Neurology Residency at Weill Cornell (Chief Resident)
- Movement Disorders Fellowship at Weill Cornell/Columbia
Dr. Gao's research centers on the gut-brain axis in Parkinson's disease, investigating alpha-synuclein pathology in the enteric nervous system as an early biomarker. Her work bridges molecular neuroscience with clinical neurology to develop diagnostic tools and therapeutic targets for neurodegeneration. She directs an NIH-funded clinical trial focused on Parkinson's biomarker discovery.
Her 15 most recent publications (2020-2025) reveal a concentrated focus on Parkinson's disease mechanisms, particularly the role of alpha-synuclein in synaptic dysfunction and gut-brain interactions. Key themes include enteric nervous system pathology as a diagnostic window, systemic influences on brain health in aging, and innovative approaches to biomarker validation through multi-omics techniques.
Major recognitions include:
- 2025 Louis and Rachel Rudin Clinical Scholar in Neurology
- 2023 Emerging Scholar Award (American Neurological Association)
- 2022 Leon Levy Fellowship in Neuroscience
- 2021 McGraw Fellowship in Neurology Research
- 2012 Ruth L. Kirchstein National Research Service Award
- 2008 Fulbright Scholarship
Dr. Gao serves as Co-Director for the Area of Concentration in Neurodegeneration for medical students and Associate Program Director for Research in the Neurology Residency Program. Her research is funded by the National Institutes of Health, Leon Levy Foundation, McGraw Fellowship, American Academy for Neurology, and the Clinical and Translational Science Center (NCATS UL1 grant 2022-2027). She leads the Parkinson's biomarker research team within the Neurology Department's Movement Disorders Institute.



